Search results
‘Gilmore Girls’ Star Scott Patterson Shares New Relationship Update Between Luke And Lorelai
HuffPost via Yahoo News Singapore· 6 months agoIt’s a happy new year indeed for the fictional townsfolk of Stars Hollow from “Gilmore Girls.” While...
Q4 2023 Crinetics Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Singapore Finance· 5 months agoParticipants Scott Struthers; Founder & CEO; Crinetics Pharmaceuticals Inc Alan Krasner; Chief Endocrinologist; Crinetics Pharmaceuticals Inc Marc Wilson; Chief Financial Officer; Crinetics ...
27 Ugly Truths About Retirement
GOBankingRates via Yahoo Singapore Finance· 3 months agoFrom dealing with unexpected medical costs to supporting adult children, Americans often find themselves facing expenses they weren't anticipating in...
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 3 months agoCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript May 11, 2024...
Endocrine Disease-Focused Crinetics Pharmaceuticals Stock Soars On Tuesday - Here's Why
Benzinga via Yahoo Singapore Finance· 4 months agoTuesday, Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) released topline results from PATHFNDR-2, the...
Starfield: Full list of player names Vasco can call you in dialogue
Windows Central via Yahoo News Singapore· 11 months agoThe internet has recently datamined Starfield and discovered a full list of names that Vasco, an...
Crinetics shares surge after "positive" hormonal disorder drug trial results
Investing.com via Yahoo Singapore Finance· 11 months agoInvesting.com -- Shares in Crinetics Pharmaceuticals (NASDAQ:CRNX) soared in early U.S. trading on Monday after the drugmaker announced the "positive results" of trials of its experimental treatment for a rare hormonal disease.
Crinetics Pharmaceuticals Inc (CRNX) Reports Increased R&D Investment Amidst Net Loss ...
GuruFocus.com via Yahoo Singapore Finance· 5 months agoResearch and Development Expenses: Increased to $168.5 million in 2023 from $130.2 million in 2022. General and Administrative Expenses: Rose to $58.1 million in 2023 from $42.4 million in 2022 ...
